Results at 72 weeks: Placebo: 3.1% weight loss Tirzepatide 5 mg: 16.0% weight loss (35.3 pounds average) Tirzepatide 10 mg: 21.4% weight loss (49.7 pounds average) Tirzepatide 15 mg: 22.5% weight loss (52.3 pounds average) The percentage of participants achieving 5% or more weight loss was 89% (5 mg), 96% (10 mg), and 96% (15 mg)
Whilst the abdomen and thigh are the most frequently recommended injection sites, many individuals choose the upper arm for convenience
Deficiency may increase noise-induced hearing loss, because their auditory nerves are already underperforming
In REDEFINE 2, which included 1,200 people with type 2 diabetes, the CagriSema group achieved a 13.7% average weight reduction (vs
Poor sleep is not one of the most common side effects of semaglutide, but some individuals may experience temporary insomnia, fatigue, or changes in sleep patterns
Introducing the Lipo Inje